Can PSMA PET scans replace the need for bone and CT scans?

A new review article suggests the possibility that radiolabeled prostate specific membrane antigens (PSMAs) and PET scans may, at some point in the not too distant future, replace bone and CT scans in diagnosis and monitoring of men with advanced forms of prostate cancer. … READ MORE …

Can gallium-68-PSMA PET/CT scans change radiation treatment decisions?

A diagnostic or prognostic technique is valuable only insofar as it is able to change treatment decisions. A small Australian study claims that gallium-68-PSMA  ([68Ga]PSMA) PET/CT scans could do this in about half the cases examined. … READ MORE …

Gallium-68 PSMA as an imaging agent in prostate cancer recurrence

A report in the Journal of Nuclear Medicine suggests that gallium-68 PSMA (68Ga-PSMA or [68Ga]PSMA) is better than an older radionuclide in detecting recurrent lesions in men with progressive prostate cancer after first-line therapy with surgery or radiation therapy. … READ MORE …